FDA Inspection 1240419 — CorePharma, LLC
The FDA completed an inspection of CorePharma, LLC on Sep 12, 2024 in Middlesex, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Middlesex, NJ (United States)